DCIS (Ductal Carcinoma in Situ) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Big Drop in Rate of Ipsilateral Breast Cancer After DCIS
(MedPage Today) -- The incidence of invasive breast cancer after conservative treatment for ductal carcinoma in situ (DCIS) decreased by more than 50% over the past 30 years, data from a Dutch cancer registry showed. Among 19,000 patients who... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 26, 2024 Category: Hematology Source Type: news

Imaging surveillance suggested for radial scars found on DBT
Imaging surveillance may be the way to go for monitoring radial scars without atypia found on screening digital breast tomosynthesis (DBT), research published March 13 in the American Journal of Roentgenology found. In a study, Claire Crowley and Manisha Bahl, MD, from Massachusetts General Hospital in Boston, found that screening-detected radial scars without atypia at core-needle biopsy have a low upstaging rate to breast cancer of less than 2%. “Our results, which show that surgical excision is not necessary for all patients with radial scars, could lead to a reduction in unnecessary surgery and could save patients ...
Source: AuntMinnie.com Headlines - March 14, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news

ECR: Momentum gathers for abbreviated MRI in high-risk breast screening
Abbreviated breast MRI is not only effective for screening among high-risk women but also useful for evaluating "pure" ductal carcinoma in situ (DCIS), according to two presentations delivered March 2 at ECR 2024. The shortened protocol offers patients a safe alternative to longer breast MRI screening exams – and streamlines radiology department workflow, said first presenter Dr. Tamara Suaris of St. Bartholomew's Hospital in London. "Abbreviated breast MRI can be considered as a safe alternative to conventional MRI studies [for] very high-risk screening, reducing MR waiting times and backlog," she noted. Abbreviated ...
Source: AuntMinnie.com Headlines - March 4, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News MRI Source Type: news

Invasive Breast Cancer, Breast Cancer Mortality Increased Long Term After DCIS
THURSDAY, Jan. 25, 2024 -- Women with non-screen-detected ductal carcinoma in situ have an increased risk for invasive breast cancer and breast cancer death, according to a study published online Jan. 24 in The BMJ. Gurdeep S. Mannu, M.B.B.S.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2024 Category: Pharmaceuticals Source Type: news

Clinical Breast Exam Rarely Detects Second Breast Cancer After DCIS
FRIDAY, Jan. 12, 2024 -- For patients undergoing surveillance following diagnosis and treatment of ductal carcinoma in situ (DCIS), very few second breast cancers are detected by clinical breast examination by a physician, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2024 Category: Pharmaceuticals Source Type: news

Clinical Exams Fall Short in Second Breast Cancer Detection Clinical Exams Fall Short in Second Breast Cancer Detection
A decade-long surveillance study shows clinical breast examinations are largely ineffective in detecting second cancers in women treated for ductal carcinoma in situ.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

DBT surveillance screening after breast cancer treatment effective
Surveillance screening via digital breast tomosynthesis (DBT) immediately after breast cancer treatment is effective, a study published on December 20 in the American Journal of Roentgenology reported. Researchers led by Dan Do from Massachusetts General Hospital reported that while the abnormal interpretation rate was higher during the year after diagnosis compared to subsequent years, it remained at less than 10% in all years of their six-year study.“The results support the study institution’s protocol for patients with a prior breast cancer diagnosis of returning immediately to screening mammography with DBT and c...
Source: AuntMinnie.com Headlines - December 21, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Subspecialties Breast Breast Imaging Source Type: news

Benign breast disease found on percutaneous biopsy ups cancer risk
Benign breast disease diagnosed through percutaneous biopsy increases the overall risk of developing breast cancer, according to research published December 13 in JAMA Surgery. A team led by Dr. Mark Sherman from the Mayo Clinic in Jacksonville, FL, found that presence of the disease on percutaneous biopsy is tied to a similar degree of increased breast cancer risk compared with surgically diagnosed benign breast disease. It also reported that the risks of both invasive breast cancer and ductal carcinoma in situ (DCIS) remained elevated among patients with the disease compared with the general population. “The finding...
Source: AuntMinnie.com Headlines - December 13, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news

Oncotype Score Helps Avoid Unnecessary Radiation in DCIS Oncotype Score Helps Avoid Unnecessary Radiation in DCIS
Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ.Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - December 11, 2023 Category: OBGYN Tags: Hematology-Oncology Source Type: news

Women With Very Early Breast Cancer May Safely Skip Radiation Rx: Study
FRIDAY, Dec. 8, 2023 -- Some women with a very early form of breast cancer known as ductal carcinoma in situ (DCIS) can safely skip follow-up radiation therapy after surgery, new research suggests.Results from a sophisticated genetic test are key... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 8, 2023 Category: General Medicine Source Type: news

CEM shows value as surveillance imaging tool
Contrast-enhanced mammography (CEM) has utility as a surveillance tool for women with a personal history of breast cancer, according to research presented December 6 at the San Antonio Breast Cancer Symposium. In her talk, Julia Matheson from the University of Melbourne in Australia shared research indicating that CEM surveillance leads to increased detection of clinically significant breast lesions, as well as lower interval cancer rates. “CEM increases the sensitivity of surveillance programs for women with a personal history of breast cancer,” Matheson said. Annual mammography with or without supplemental ultra...
Source: AuntMinnie.com Headlines - December 6, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Breast Source Type: news

Biomarker model predicts breast cancer risk without racial bias
CHICAGO -- A new breast cancer risk assessment technique that uses mammography biomarkers shows no racial bias, according to research presented November 29 at the RSNA meeting.The findings offer another way to foster breast cancer early detection, improve patient survival rates across different populations, and reduce disparity in survival rates, said study lead author Leslie Lamb, MD, of Massachusetts General Hospital (MGH) in Boston in a statement. “In the domain of precision medicine, risk-based screening has been elusive because we have not been able to accurately evaluate a woman’s risk of developing breast cance...
Source: AuntMinnie.com Headlines - November 29, 2023 Category: Radiology Authors: Liz Carey Tags: Subspecialties Womens Imaging Breast Imaging RSNA 2023 Source Type: news

ASTRO proposes new guidelines for aggressive breast cancer and DCIS
The American Society for Radiation Oncology (ASTRO) has released a proposed update to clinical practice guidelines for partial breast radiation as an alternative to whole breast radiation for early-stage invasive breast cancer and ductal carcinoma in situ (DCIS). ASTRO’s recommendations are based on evidence from major clinical trials, said Janice Lyons, MD, chair of the guideline task force at the University Hospitals Seidman Cancer Center in Cleveland, OH, in a statement released by the society. The new guidance also addresses aspects related to the technical delivery of partial breast irradiation (PBI), including do...
Source: AuntMinnie.com Headlines - November 17, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Subspecialties Radiation Oncology Source Type: news

ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancer
(MedPage Today) -- The American Society for Radiation Oncology (ASTRO) updated their guidelines on partial breast irradiation (PBI) for patients with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS). These new guidelines take... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 16, 2023 Category: Hematology Source Type: news

Mammography-based nomogram predicts breast microcalcifications
A mammography-based radiomic nomogram could be useful in predicting risk of malignancy in suspicious breast microcalcifications, according to research published November 7 in Academic Radiology. A team led by Yusi Chen from the Second Affiliated Hospital of Harbin Medical University in China found that the nomogram, which combined radiomic scoring with clinical factors, achieved a high area under the curve (AUC) value in a validation set of patients with breast microcalcifications. “The combined model could be considered as a potential imaging marker to predict malignant risk,” Chen and colleagues wrote. Differentia...
Source: AuntMinnie.com Headlines - November 8, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Advanced Visualization Breast Imaging Source Type: news